PATENT CLAIM ANALYSIS

Application Number: 15906934
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "210180"]

Abstract:
The present disclosure provides a compound of formula (I) and the use thereof for the therapeutic treatment of human cancers including B-cell lymphoma and autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.

Claim (Index 49):
The compound of  claim 40 , a pharmaceutically acceptable salt, a solvate, or a hydrate thereof, wherein B is phenyl substituted with two Cl.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.13889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15323929', '14708099', '14081053', '13828285', '15309396']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6860060213376722
- 35 USC 102 Novelty (BERT): 0.5226006083652984
- Combined Prediction Score: 0.6696654800404349
- Mean Citation Score: 266.72180799999995
- Max Citation Score: 289.41644
- Similarity Product: 203.5698185410333

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test